EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

Carolina Jiménez-González, Marta Alonso-Peña iD, Paula Argos Vélez, Javier Crespo iD, Paula Iruzubieta

Nutrients · 2025

DOI: 10.3390/nu17091580 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Carolina Jiménez-González und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqué…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Artificial Intelligence, Life Style, Diet. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Instituto de Salud Carlos III, European Union-NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota has a crucial role in the pathophysiology of metabolic-associated steatotic liver disease (MASLD), influencing various metabolic mechanisms and contributing to the development of the disease. Dietary interventions targeting gut microbiota have shown potential in modulating microbial composition and mitigating MASLD progression. In this context, the integration of multi-omics analysis and artificial intelligence (AI) in personalized nutrition offers new opportunities for tailoring dietary strategies based on individual microbiome profiles and metabolic responses. The use of chatbots and other AI-based health solutions offers a unique opportunity to democratize access to health interventions due to their low cost, accessibility, and scalability. Future research should focus on the clinical validation of AI-powered dietary strategies, integrating microbiome-based therapies and precision nutrition approaches. Establishing standardized protocols and ethical guidelines will be crucial for implementing AI in MASLD management, paving the way for a more personalized, data-driven approach to disease prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeArtificial IntelligenceLife StyleDietNon-alcoholic Fatty Liver DiseaseFatty LiverHumansPrecision Medicine

Stichwörter der Autor:innen

MASLDartificial intelligencedietary patternsgut microbiotalifestyle modificationsmulti-omics

Autor:innen und Institutionen

  • Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, 39011 Santander, Spain.
  • Departamento de Anatomía y Biología Celular, Universidad de Cantabria, 39011 Santander, Spain.

ORCID-Profile: Marta Alonso-Peña, Javier Crespo

Förderung

  • European Commission
  • Instituto de Salud Carlos III
  • European Union-NextGenerationEU
  • European Horizon’s research and innovation program HORIZON-HLTH-2022-STAYHLTH-02
  • Spanish Instituto de Salud Carlos III-FEDER Grant

Zitieren

APA

Jiménez-González, C., Alonso-Peña, M., Argos Vélez, P., Crespo, J., & Iruzubieta, P. (2025). Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions. Nutrients. https://doi.org/10.3390/nu17091580

Vancouver

Jiménez-González C, Alonso-Peña M, Argos Vélez P, Crespo J, Iruzubieta P. Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions. Nutrients. 2025. doi:10.3390/nu17091580

BibTeX
@article{JimnezGonzlez2025,
  author = {Jiménez-González, Carolina and Alonso-Peña, Marta and Argos Vélez, Paula and Crespo, Javier and Iruzubieta, Paula},
  title = {Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17091580}
}
Kostenlos starten →